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Impact of Depression on Long-Term Outcome After
Renal Transplantation: A Prospective Cohort Study
Dorien M. Zelle,1,5 Heleen F. Dorland,2 Judith G. M. Rosmalen,3 Eva Corpeleijn,2 Reinold O. B. Gans,4
Jaap J. Homan van der Heide,1 Willem J. van Son,1 Gerjan Navis,1 and Stephan J. L. Bakker1
Background. Renal transplantation is the treatment of choice for end stage renal disease. Although there is more
depression in wait-listed versus transplant patients, depression persists after transplantation. We investigated the
determinants of depression in renal transplantation recipients (RTRs) and the association with cardiovascular (CV)
and all-cause-mortality and graft failure.
Methods. RTR were investigated between 2001 and 2003. Depression was assessed using the Depression Subscale of
the Symptom Checklist (SCL-90). Mortality and graft failure were recorded until May 2009.
Results. A total of 527 RTR (age, 51T12 years; 55% men) were studied; 31% of the RTR were indicated with de-
pression. Independent variables associated with depression were medically unfit for work, proteinuria, lower physical
activity level, and longer dialysis duration. During follow-up for 7.0 (6.2Y7.5) years, 114 RTR (59 CV) died. In Cox
regression analyses, depression was strongly associated with increased risk for CV (HR=2.12 [1.27Y3.53], P=0.004)
and all-cause mortality (HR=1.96 [1.36Y2.84], PG0.001). Adjustments for confounders did not materially change
these associations. The association with graft failure (HR=1.77 [1.01Y3.10]. P=0.047) disappeared after adjustment
for kidney function (P=0.6).
Conclusions. Although our study has several limitations, including the lack of pretransplant depression status, we
identified medically unfit for work, proteinuria, lower physical activity level, and longer dialysis duration as inde-
pendent variables associated with depression. We furthermore found that depression is associated with CV and all-
cause mortality in RTR.
Keywords: Depression, All-cause mortality, Cardiovascular mortality, Graft failure.
(Transplantation 2012;94: 1033Y1040)
Transplantation is the preferred treatment in end-stagerenal disease (ESRD). Compared with maintenance di-
alysis, it offers significant survival advantage and brings
emotional and psychological benefits to patients. On the
other hand, it also introduces new concerns such as fear of
losing the new kidney and complications that may lead to
emotional distress (1Y3). Although there is more depression
in wait-listed versus transplant patients, depression seems to
be a persistent problem after transplantation (4).
Research among individuals with chronic medical con-
ditions, such as type 2 diabetes and coronary artery disease,
shows that depressed patients have increased mortality com-
pared with their nondepressed counterparts (5Y9). Various
studies have shown that depression is common among
patients on dialysis, with a prevalence of depression ranging
from 5 to as high as 71% (10), depending on the study
population and method of diagnosis. We also know that
depression has been associated with increased morbidity
and mortality in ESRD (11, 12).
There is only limited data about the prevalence of
depression after renal transplantation, and few studies were
done on the relation of depression with long-term outcome.
Dobbels et al. (13) show that depression is associated with a
twofold greater risk of graft failure and death. Novak et al.
(14) show that mortality in patients with depression after
kidney transplantation was higher than in patients without
depression. No data are available about the risk of cardio-
vascular mortality in RTR in relation to depression. Early
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TABLE 1. Baseline characteristics according to groups of depression score
Depression score (SCL-90)
No-depression: score G25 (n=366) Possible depression: score 925 (n=161) P
General characteristics
Age (yr) 51.16T11.85 51.38T12.03 0.84
Sex (male), n (%) 209 (57) 81 (50) 0.15
Living alone, n (%) 56 (15) 32 (20) 0.21
Employment status
Paid employment 139 (39) 126 (21) G0.001
Medically unfit for work, n (%) 80 (22) 68 (42) G0.001
Unemployed, n (%) 70 (20) 23 (14) 0.16
Retired, n (%) 30 (8) 15 (9) 0.7
Unspecified, n (%) 34 (9) 16 (10) 0.85
Lifestyle
Metabolic Syndrome, n (%) 242 (66) 101 (63) 0.45
Physical activity (METS) 147.82 (37.08Y345.17) 90.15 (8.36Y227.30) G0.001
Smoking
- In the past, n (%) 152 (42) 74 (46) 0.34
- Currently, n (%) 79 (22) 41 (26) 0.33
Alcohol consumption
- Abstainers, n (%) 170 (46) 75 (47) 0.96
- G10 g/d, n (%) 140 (38) 64 (40) 0.80
- 10Y30 g/d, n (%) 51 (14) 18 (11) 0.37
- 930 g/d, n (%) 2 (1) 4 (3) 0.06
Body composition
Body mass index (kg/m2) 26.23T4.29 25.81T4.40 0.31
Waist circumference (cm) women 94.23T14.21 93.35T15.68 0.67
Waist circumference (cm) men 100.49T12.74 98.92T12.20 0.34
Urinary creatinine excretion (mmol/24 hr) 11.85 (9.73Y14.58) 11.70 (8.85Y13.95) 0.05
History of cardiovascular disease
Myocardial infarction, n (%) 27 (7) 12 (8) 0.22
CVD event, n (%) 54 (15) 28 (17) 0.44
Antidepressant use
Selective serotonin re-uptake inhibitors n (%) 7 (2) 12 (7) 0.002
Tricyclic antidepressants n (%) 3 (1) 1 (1) 0.8
Benzodiazepines n (%) 14 (4) 25 (16) G0.001
Vitamin D status
25(OH)D (nmol/L) 51.4 (37.5Y68.9) 47.4 (35.4Y67.2) 0.21
Hemoglobin level
Hemoglobin (mmol/L) 8.7 (8.1Y9.3) 8.4 (7.7Y9.2) 0.03
Blood pressure
Systolic blood pressure (mmHg) 152.75T22.52 154.70T23.62 0.36
Diastolic blood pressure (mmHg) 90.14T9.81 89.94T9.81 0.84
Antihypertensive medication, n (%) 339 (93) 149 (93) 0.98
Use of ACE inhibitor, n (%) 139 (38) 46 (29) 0.04
Use of A-blocker, n (%) 230 (63) 99 (62) 0.77
Lipids and inflammation
Total cholesterol (mmol/L) 5.64T1.14 5.61T1.04 0.76
HDL-cholesterol (mmol/L) 1.09T0.33 1.11T0.31 0.55
Low-density lipoprotein cholesterol (mmol/L) 3.57T1.07 3.56T0.88 0.91
Triglycerides (mmol/L) 1.92 (1.42Y2.61) 1.89 (1.39Y2.64) 0.59
hsCRP (mg/L) 2.13 (0.93Y4.60) 2.64 (0.77Y7.46) 0.30
(Continued on next page)
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identification of patients at risk is hampered by the lack of
knowledge about the determinants of depression in RTR.
Therefore, recipient-related factors, such as proteinuria,
blood pressure, and lifestyle factors, need to be explored for
their potential association with depression (12Y14).
We hypothesize, first, that there is a high prevalence
of depression in RTR and, second, that symptoms of de-
pression may lead to a worse survival and graft failure, the
former possibly attributable to cardiovascular disease. To
study these hypotheses, we investigated several recipient-
related factors for their association with depression in
RTR in a large single-center cohort. We furthermore aimed to
investigate whether symptoms of depression are associated
with cardiovascular and all-cause mortality and graft survival.
RESULTS
A total 527 RTRs (mean age, 51T12 years; 55% male
subjects) participated at median time of 6.0 (2.6Y11.4) years
posttransplant. The median SCL-90 score on depression in
the RTR was 21 [25thY75th percentile; 18Y26]; 31% (n=161)
of the RTR scored above the cutoff score of 25 and were
categorized as depressed (median SCL-90 score 30 [27Y39]).
Baseline characteristics of the RTR according to the two
groups of depression score are shown in Table 1. Depressed
RTR had significantly lower physical activity level, urinary
creatinine excretion, hemoglobin levels, ACE inhibitor in-
take, and creatinine clearance; had less often paid employ-
ment; and had less often a living donor. Depressed patients
also were more often medically unfit for work, had more
often proteinuria, had a longer history of dialysis, and used
more often antidepressant medication. Use of SSRIs or
TCAs in the total population was 4%.
Independent variables associated with depression in
RTR are shown in Table 2. Medically unfit for work, pro-
teinuria, low physical activity level, and longer previous di-
alysis duration were the most important independent
determinants of depression in a logistic regression analysis.
During median follow-up for 7.0 [6.2Y7.5] years, 114
recipients died, with 59 deaths being cardiovascular (CV)
TABLE 1. (Continued)
Depression score (SCL-90)
No-depression: score G25 (n=366) Possible depression: score 925 (n=161) P
Glucose homeostasis
Glucose (mmol/L) 4.88T1.38 4.83T1.42 0.71
Insulin (Kmol/L) 11.4 (4.80Y16.33) 10.9 (7.90Y14.75) 0.61
Diabetes mellitus, n (%) 66 (18) 28 (17) 0.86
Renal function
Serum creatinine (Kmol/L) 132 (111.75Y167.00) 137 (114Y169.5) 0.24
Creatinine clearance (mL/min) 62 (49Y79) 57 (42Y75) G0.01
Urinary protein excretion (g/24 h) 0.2 (0.00Y0.50) 0.3 (0.00Y0.60) 0.11
Proteinuria Q0.5 g/24 h, n (%) 92 (25) 60 (37) 0.01
Transplantation and history
Dialysis duration (mo) 25 (12Y45.25) 31 (17Y56) G0.01
Living donor, n (%) 61 (17) 14 (9) 0.02
Time since transplantation (yr) 5.81 (2.51Y11.10) 6.52 (2.82Y12.20) 0.53
Number of previous transplants
- 0, n (%) 331 (90) 137 (85) 0.07
- 1 or more, n (%) 35 (10) 24 (15)
Acute rejection, n (%) 163 (45) 74 (46) 0.76
Immunosuppression
Prednisolone dose, mg/d 9.17T1.33 9.29T1.21 0.59
Calcineurine inhibitor, n (%) 287 (78) 125 (78) 0.84
Proliferation inhibitor, n (%) 270 (74) 121 (75) 0.74
Tacrolimus (trough level, ug/L) 8.64T2.76 8.64T5.31 0.99
Cyclosporine (trough level, ug/L) 114.10T47.98 112.99T46.42 0.85
Data are represented as meanTSD, or median (95% CI). Differences were tested by t test or Kruskal-Wallis test for continuous variables and with chi-
square for categorical variables.
TABLE 2. Independent determinants of depression
Multivariable Exp(B) (95% CI) P
Medically unfit for work 2.48 (1.52Y4.04) G0.001
Proteinuria (Q0.5 g/24 hr) 2.18 (1.34Y3.53) 0.002
Physical activity (200 METS) 0.65 (0.44Y0.98) 0.039
Dialysis duration (yr) 1.08 (1.01Y1.15) 0.028
* 2012 Lippincott Williams & Wilkins Zelle et al. 1035
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in origin. PTA was performed twice (3%), PTCA was per-
formed once (2%), and CABG was performed in 3 (5%)
RTR. Cardiovascular mortality was significantly increased in
the depression group as compared with the no-depression
group (27 [17%] vs 32 [9%], respectively P=0.004; Fig. 1A).
The same was found for all-cause mortality, with respective
numbers of 64 (18%) and 50 (31%) (PG0.001, Fig. 1B).
Results of the Cox regression analyses for the associ-
ation of depression with cardiovascular (CV) and all-cause
mortality are shown in Table 3. Depression was strongly
associated with increased risk for CV mortality and all-cause
mortality (model 1). These associations were independent of
age and gender (model 2). Adjustment for dialysis duration
(model 3), creatinine clearance and proteinuria (model 4),
hemoglobin levels (model 5), physical activity level (model
6), and medically unfit for work (model 7) did not materi-
ally change the association.
During median follow-up for 7.0 (6.2Y7.5) years, a
total of 50 (9%) RTR experienced graft failure necessitating
return to dialysis. In the no-depression group, 29 (8%) of
the RTR experienced graft failure compared with 21 (13%)
in the possible depression group (P=0.04, Fig. 1C). Results
of Cox regression for depression and graft failure are shown
in Table 4. Depression was associated with a higher risk for
graft failure. After adjustments for proteinuria and creati-
nine clearance, the relationship disappeared.
DISCUSSION
In this study, we showed that the prevalence of de-
pression after transplantation is high. Important indepen-
dent variables associated with depression were medically
unfit for work, proteinuria, low physical activity, and longer
dialysis duration. Furthermore, we showed that depression
was associated with CV, all-cause mortality, and graft failure
in RTR.
In our study, 31% RTR were categorized as depressed
based on the depression cutoff score of the SCL-90 ques-
tionnaire. This number of occurrence is higher than that in
the general population (15.9%) (15) but comparable with
other studies, which were also based on self-reported de-
pressive symptoms (14, 16, 17). The large study by Dobbels
et al. (13) in patients from the United States Renal Data
System reported a much lower prevalence of 9% to 13%,
FIGURE 1. A, Kaplan-Meier curve of cardiovascular mortality according to depression score groups tested with Log-rank
test (PG0.001).B, Kaplan-Meier curve of all-cause mortality according to depression score groups tested with Log-rank test
(P=0.004). C, Kaplan-Meier curve of graft failure according to depression score groups tested with Log-rank test (P=0.04).
TABLE 3. Depression is associated with cardiovascular and all-cause mortality
Cardiovascular mortality (n=59) All-cause mortality (n=134)
No depression Possible depression No depression Possible depression
Model Reference HR (95% CI) P Reference HR (95% CI) P
1 1.0 2.12 (1.27Y3.53) 0.004 1.0 1.96 (1.36Y2.84) G0.001
2 1.0 2.06 (1.23Y3.45) 0.006 1.0 1.92 (1.33Y2.79) 0.001
3 1.0 1.94 (1.16Y3.26) 0.012 1.0 1.89 (1.30Y2.74) 0.001
4 1.0 1.84 (1.09Y3.11) 0.022 1.0 1.74 (1.19Y2.55) 0.004
5 1.0 1.85 (1.09Y3.12) 0.022 1.0 1.74 (1.19Y2.54) 0.005
6 1.0 1.82 (1.07Y3.09) 0.026 1.0 1.73 (1.18Y2.54) 0.005
7 1.0 1.73 (1.01Y2.94) 0.045 1.0 1.61 (1.09Y2.37) 0.016
Model 1: crude model. Model 2: model 1 + adjustment for age and gender. Model 3: model 2 + adjustment for dialysis duration (months) Model 4: model
3 creatinine clearance and for proteinuria (Q0.5 g/24 hr) Model 5: Model 4 + adjustment for hemoglobin. Model 6: model 4 + adjustment for physical activity.
Model 7: model 4 + adjustment for medically unfit for work.
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3 years after transplantation. In that study, diagnoses of
depression were based on Medicare claims, which, as the
authors say, probably underestimate the real prevalence of
depression after renal transplantation (13).
We identified several important independent vari-
ables associated with depression after renal transplantation.
In our study, medically unfit for work is the strongest in-
dependent variable associated with depression. Medically
unfit for work can be the consequence of a bad physical
health, leading to more depressive symptoms. The other way
around, depression can lead to a bad physical health, which
can lead to being unable to work. Proteinuria was the sec-
ond strongest independent variable associated with depres-
sion. The burden of disease in these patients is higher, which
gives more psychological distress and a higher risk for de-
pression. Twenty-four hours of protein excretion was only
retained in the final model of determinants of depression if
it was included as a dichotomized variable with proteinuria
defined as 0.5 g/24 h or greater, indicating that risk is par-
ticularly present in the high end of the distribution of 24 h
protein excretion. Physical activity is also strongly associated
with depression. Depression can negatively influence life-
style behaviors like physical activity, which would add to
risk consequences of low physical activity that is already
present in RTR (18). We found that longer dialysis duration
is a factor that is related to possible depression. Renal
transplantation recipients with a longer duration of dialysis
have a longer history of chronic kidney disease, increasing
the risk for comorbidity and mortality (19). These findings
are in line with the notion that depression can be caused by
psychological distress from a higher burden of disease.
Besides these important variables described above, we
know from the literature that immunosuppressive medica-
tion could also influence depression (20). In the general
population, use of corticosteroids is associated with de-
pression (20). Brown et al. (21) show that the risk for de-
pression seems to increase with higher corticosteroid doses.
It is, however, difficult to determine whether depression is
caused by steroidal treatment or by a higher burden of dis-
ease. In our study, however, we did not find a relationship
between corticosteroids and depression. This may be the
consequence of low variation in steroid doses in the popu-
lation we investigated, which did not allow for us finding
such a relationship. Tryptophan metabolism may provide a
link between renal function and depression. Rosso et al. (22)
hypothesized about the role of tryptophan in psychopa-
thology and somatic states. Even mild degrees of renal in-
sufficiency as often encountered in RTR are associated with
chronic low-grade inflammation. Chronic inflammation in
turn leads to a high activity of indoleamine 2,3-dioxygenase
(IDO), resulting in low tryptophan levels, with insufficient
amounts for the formation of serotonin, resulting in de-
pression (23). In line with this, Pawlak et al. (24) showed
that dialyzed patients have significantly lower tryptophan
than controls. Further research is needed to explore whether
this mechanism plays a role in RTR.
The association of depression with mortality and graft
failure could have been confounded by comorbidity or a
complex recovery after transplantation. Several chronic ill-
nesses are associated with psychiatric comorbidity. Noohi
et al. (25) found an increased morbidity among depressed
RTR, compared with nondepressed RTR. Renal transplan-
tation recipients with proteinuria are at higher risk for graft
failure, comorbidity, and mortality (26). Patients with low
GFR may have an increased physical symptom burden (27).
In our Cox regression analyses for CV and all-cause mor-
tality, we therefore adjusted for creatinine clearance and
for proteinuria. Upon these analysis, hazard ratio for all-
cause mortality decreased from 1.89 (1.30Y2.74) to 1.74
(1.19Y2.55), remaining significant. Showing that creatinine
clearance and proteinuria only explain a very small part of
the association. The relationship between depression and
graft failure was confounded by a deterioration of kidney
function. Another potential confounder of the association of
depression with mortality in RTR could be dialysis duration.
Longer dialysis duration means that patients are longer ex-
posed to the chronic effects of end-stage renal failure and
dialysis treatment. Dialysis treatment is associated with al-
tered inflammatory state, altered immunologic function and
acceleration of atherosclerosis (28Y30). Previous studies
showed that dialysis duration was associated with risk for
mortality and graft failure in RTR (19, 31). In our study,
dialysis duration was strongly associated with symptoms of
depression. This is in line with the study of Dobbels et al.
(13), in which patients with high depressive symptoms had
significant longer dialysis duration, compared with patients
with moderate or low depressive symptoms. Although we
found that dialysis duration was related to depression, it was
not significant in the Cox regression analysis. As hemoglo-
bin level is an important risk factor for outcome in RTR, we
additionally adjusted for hemoglobin levels (32); this ad-
justment did not change the results. We previously showed
that low physical activity is a risk factor for mortality in RTR
(18, 33); therefore, we adjusted for physical activity in our
analysis. Upon this analysis, physical activity level did ex-
plain a small part of the association. Unfit for work refers
to the status that RTR are physically or mentally unfit for
work, which can be a result of a long history of chronic
kidney disease and transplantation with possible complica-
tions, together representing a substantial overall burden of
disease. Adjustment for this confounder showed that part of
the association was explained by medically unfit for work.
Although we adjusted for all potential confounders, residual
confounding could not be ruled out.
TABLE 4. Association between depression and graft
failure disappears after adjustment for kidney function
Graft failure (n=50)
No depression Possible depression
Model Reference HR (95% CI) P
1 1.0 1.77 (1.01Y3.10) 0.047
2 1.0 1.82 (1.04Y3.20) 0.037
3 1.0 1.93 (1.09Y3.41) 0.024
4 1.0 1.19 (0.66Y2.11) 0.6
Model 1: crude model. Model 2: model 1 + adjustment for age and
gender. Model 3: model 2 + adjustment for dialysis duration (months).
Model 4: model 3 + adjustment for proteinuria (Q0.5 g/24 hr) and creati-
nine clearance.
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There are several pathways that could explain the re-
lationship between symptoms of depression and mortality.
Depression could be a result of a long history of chronic
kidney disease and transplantation with possible complica-
tions, together representing a substantial overall burden of
disease. We will distinguish between biological, lifestyle, and
psychosocial factors to describe the possible mechanisms
that could explain the relationship between depression and
outcome after renal transplantation. Results from a large
systematic review showed that there is a link between de-
pression and increased risk for cardiovascular disease (34).
This is in line with our study, were cardiovascular mortality
is strongly associated with depression. Research into possi-
ble mechanisms of depression in cardiovascular disease
shows that much of the association remains unclear because
of the complexity of the network of systems involved (35).
Lifestyle factors are important factors in the association
between depression and mortality. In our study, depressive
symptoms were associated with an unhealthy lifestyle. Renal
transplantation recipients with more depressive symptoms
had significantly lower physical activity levels and were more
likely to consume more than three alcoholic drinks per day.
These unhealthy lifestyle behaviors may directly or indirectly
lead to mortality. We previously showed that low physical
activity was a strong independent predictor for CV and all-
cause mortality in RTR (18). Whereas moderate alcohol con-
sumption is protective in RTR, alcohol dependence before
transplantation is related to mortality and graft failure (36).
Lifestyle factors are modifiable, which offers an opportu-
nity for intervention toward a healthier lifestyle in RTR.
Psychosocial factors might modulate the relationship
between depressive symptoms and mortality. A potential
cause of death in patients with high depressive symptoms
relates to compliance with therapy. DiMatteo et al. (37)
showed that depressed patients had a threefold greater risk
of nonadherence behavior. Depressive symptoms like feel-
ings of hopelessness and difficulties with memory may result
in behaviors that include forgetting to take pills or missing
regular follow-up appointments (37). In kidney and pan-
creas transplantation patients and patients with coronary
artery disease, noncompliance with therapy adversely affects
the recovery and subsequent life (38Y40). In our study,
however, we did not find any differences in trough levels of
tacrolimus and cyclosporine.
In most clinics, there is no active screening program
for depression after transplantation. Based on the low anti-
depressant use in our study (4 %), depression after renal
transplantation is presumably under diagnosed and under
treated. Screening for depression in RTR could therefore
be useful in this high-risk population. Further research is
needed to develop and evaluate these screening programs
and consequently apply existing interventions studies tar-
geting depression. Perceived control could be an important
target for intervention in managing the high stress levels in
the recovery after transplantation. Cukor et al. (41) found
that transplantation recipients who had better perceived con-
trol over their outcome had decreased levels of depression,
compared with patients who attributed their health outcome
to chance. In this respect, self-management is important. Self-
management strategies should be stimulated and guided by
the health-care professionals and can be incorporated in the
health-care treatment plan. Self-management strategies can
be used to target behaviors like: exercise, diet, smoking, and
adherence to medication.
A strength of our study is its prospective design. Renal
transplantation recipients in this study were closely moni-
tored by regular check-up in our clinic, which allows for
extensive information gathering on patients status.
We furthermore assessed depression using the De-
pression Subscales of SCL-90. This subscale measures only
psychological depressive symptoms and no somatic symp-
toms of depression. This makes the depression subscale
more suitable for measuring depression in RTR. Some de-
pression questionnaires do not distinguish between depres-
sive and somatic symptoms, which can lead to unreliable
results in patients with chronic disease.
Some methodological topics warrant consideration.
First, we used a self-report questionnaire for measuring
depression, which is informative but does not replace diag-
nosis of depression by psychiatric clinical assessment ac-
cording to the Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition, criteria for major or minor de-
pression. Nevertheless, questionnaires are valuable screening
instruments for depressive symptoms in large epidemio-
logical studies, and the questionnaire was validated against
the Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition, criteria for major or minor depression, in
stroke patients (42). It remains unclear, however, whether the
validation of the cutoff values in stroke patients, 1 month
after they experienced their first-ever ischemic stroke, may
be of influence on the classification of depression in RTR (42).
In a sensitivity analysis (data not published), the use of the
depression score as a continuous variable were comparable
to the findings of depression assessed with cutoff values.
Next, this study is based on a single measurement design; it
is possible that depressive symptoms could have changed
over time. Pretransplant information on depression is not
available in this study. Multiple measurements of depres-
sion and pretransplant information on depressive symptoms
would have strengthened our results. Information on psy-
chotherapy was unavailable in this study. Moreover, this
study is observational in design, and thus, conclusions on
causality cannot be drawn. Multiple measurements of de-
pression would have strengthened our results. Also, no in-
formation was available on the use of antidepressant agents.
In summary, depression is a condition that is very
common among RTR. Independent risk factors for depres-
sion were medically unfit for work, proteinuria, lower physi-
cal activity level, and longer dialysis duration. Our data show
that depression after kidney transplantation is a serious con-
dition associated with reduced patient and graft survival.
Based on the association between symptoms of depression
and mortality, it is tempting to speculate that reduction of
depressive symptoms could contribute to improved survival
in RTR. Additional studies on detection and treatment of
depression after renal transplantation are needed.
MATERIALS AND METHODS
Design and Subjects
Study design and inclusion/exclusion criteria have been described pre-
viously (18). In brief, for this prospective cohort study, all adult allograft
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recipients between August 2001 and July 2003 who survived with a func-
tioning allograft beyond the first year after transplantation were eligible to
participate at their next visit to the outpatient clinic. A total of 606 RTR
signed written informed consent, from an eligible 847. Data on depression
were available in 527 RTR. Baseline data were collected between August
2001 and July 2003, and RTR were followed for several years. The institu-
tional review board approved the study protocol.
End Points of the Study
The primary end points of this study were recipient mortality and graft
failure. Graft failure was defined as a return to dialysis or retransplantation.
The continuous surveillance system of the outpatient program ensures up-
to-date information on patient status and cause of death. We contacted
general practitioners or referring nephrologists if the status of a patient was
unknown. For this study, we used follow-up data for mortality and graft
loss, recorded until May 2009.
We also collected follow-up data on percutaneous transluminal angio-
plasty (PTA), percutaneous transluminal coronary angioplasty (PTCA) and
coronary artery bypass grafting (CABG). Cause of death was obtained by
linking the number of the death certificate to the primary cause of death
as coded by a physician from the Central Bureau of Statistics. Causes of
death were coded according to the International Classification of Diseases,
9th revision (ICD-9) (43).
Renal Transplant Characteristics
The Groningen Renal Transplant Database contains information on all
renal transplantations performed at our center since 1968. Relevant trans-
plant characteristics such as age, gender, and date of transplantation were
extracted from this database. Current medication was taken from the medi-
cal record. Standard immunosuppressive treatment was described previously
(44). Information on employment status, living situation, smoking and
alcohol consumption, and cardiovascular history were obtained by self-
report questionnaire.
Depression
Quantitative information on depression was obtained by the Depres-
sion Subscales of the Symptom Checklist (SCL-90). The SCL-90 is the
screening instrument most commonly used by psychologists in clinical
practice as well as in research settings in the Netherlands (45). The SCL-90
is widely used as an outcome measure in intervention studies and as a
screening instrument in both psychiatric and medical patients for clinical
and research purposes (46Y48). SCL-90 is designed to measure a broad
range of psychological problems and symptoms of psychopathology and has
shown to have good psychometric properties (49, 50). The SCL-90 de-
pression subscale measures the typical symptoms of depression; dysphoric
mood, signs of withdrawal of life interest, lack of motivation, and loss of
vital energy. Feelings of hopelessness and thoughts of suicide are also in-
cluded in the depression subscale. The SCL-90 depression subscale was
administered once in all RTR between August 2001 and July 2003. In the
depression subscale, patients are asked to indicate on a five-point scale how
much hindrance they experienced from psychiatric complaints in the last
week. The depression subscale measures only psychological depressive
symptoms and no somatic symptoms of depression. The depression sub-
scale was validated in patients who experienced their first-ever ischemic
stroke. The C-statistic of the SCL-90 depression subscale was 0.81 (42). For
the indication of possible depression, we used a cutoff score of 25 on the
depression subscale. Sensitivity and specificity of this threshold were 88.5
and 60.7, respectively (42).
Measurements and Definitions
Physical activity was assessed using validated questionnaires (18). Single
imputation was used to obtain more complete data on physical activity.
Body mass index, waist circumference, and blood pressure were measured
as described previously (18).
Blood was drawn after an overnight fasting period, which included no
intake of medication. Total cholesterol, low-density lipoprotein cholesterol,
high-density lipoprotein cholesterol, serum triglycerides, glucose, insulin,
24-hour creatinine excretion as a measure for muscle mass (51), serum and
urine creatinine concentration were measured as described previously (18);
25-hydroxyvitamin D3 levels were determined using isotope dilutionY
online solid phase extraction liquid chromatographyYtandem mass spec-
trometry. Proteinuria was defined as urinary protein excretion of 0.5
g/24 h or higher. Metabolic syndrome (MS) and diabetes were defined
according to the guidelines as described previously (43). Medically unfit
for work applies to both the physical and mental status of a patient.
Statistical Analyses
Data were analyzed with SPSS version 19.0 (SPSS Inc., Chicago, IL) and
GraphPad Prism version 5.01 (GraphPad Software, San Diego, CA). Nor-
mally distributed variables were expressed as meanTSD, whereas skewed
distributed variables are given as median (25thY75th percentile); percent-
ages were used to summarize categorical variables. Log transformation was
used for variables with a skewed distribution. Hazard ratios are reported
with 95% confidence interval.
Recipient-related characteristics were analyzed separately for the group
below the cutoff score of 25 and the group above this score. Differences
between groups were tested for statistical significance with Student t test for
normally distributed variables, Mann-Whitney test for skewed distributed
variables, and chi-squared test for categorical variables. Forward logistic
regression analysis was performed including all variables with a PG0.1 to
determine independent determinants of depression. All covariates from
Table 1 with a PG0.2 were used in the logistic regression. To analyze
whether symptoms of depression are associated with cardiovascular and all-
cause mortality, and graft failure, we performed Kaplan-Meier analysis with
log rank test to assess significance of difference between groups. Cox re-
gression analyses were performed to study whether depression was inde-
pendently associated with cardiovascular and all-cause mortality and graft
failure. In these analyses, we considered several potential covariates known
to be associated with mortality and graft failure in RTR as well as covariates
that were independently associated with depression (18, 19, 26, 32, 33).
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